When? Wednesday, August 9 at 11am EST, 4pm BST
Length: 45 minutes
Real world evidence can inform all phases of drug development, commercialization, and drug use in healthcare settings. Many sources of real world data contain large amounts of unstructured text (e.g. EHRs; patient-reported outcomes such as forums, social media). NLP text mining can extract the key facts, using relevant ontologies and focused queries, transforming real world data into actionable intelligence for decision making.
In this 40-minute webinar, RealHealthData and Linguamatics will discuss the challenges of working with real world data (in this case, medical transcripts), and show the power of I2E to extract relevant data to answer critical questions around treatment outcomes for prostate cancer.
During the webinar, you will learn about:
- How NLP text mining can help your integrated approach to transforming unstructured RWD
- The power of unstructured patient narratives to inform your product decisions
- Explore how to inform better patient care through developing better evidence
Who should attend?
Professionals in Health Economics and Outcomes Research, Real World Evidence, Medical affairs, Scientific affairs, Real World Strategy and Analytics, Patient Centricity and Personalized Medicine
About the webinar presenters:
Joe Turner, VP Operations, RealHeathData
Joe Turner is the VP of Operations at RealHealthData. He has over 12 years of experience in building, querying and constructing medical record databases and extracting value from them. He and his team are responsible for maintaining the RHD database, managing its growth and integrity, building queries using the I2E platform and working directly with clients on their projects.
Jane Reed, Head of Life Science Strategy, Linguamatics
Jane Reed leads the strategic vision for Linguamatics’ growing product portfolio and business development in the life science domain. Jane has extensive experience in life sciences informatics. She worked for more than 15 years in vendor companies supplying data products, data integration and analysis and consultancy to pharma and biotech - with roles at Instem, BioWisdom, Incyte, and Hexagen. Before moving into the life science industry, Jane worked in academia with post-docs in genetics and genomics.
